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ABSTRACT 
The effect of Human Immunodeficiency Virus (HIV) and possibly Highly Active Antiretroviral Therapy (HAART) on pregnancy 
and neonatal outcomes has been a controversial issue with some researches reporting no association while others reporting 
significant association. This study aimed at comparing the pregnancy and neonatal outcomes between Human Immunodeficiency 
Virus (HIV) positive women and HIV negative women who delivered at University College Hospital (UCH), Ibadan. This study 
was a cross-sectional study carried out at the University College Hospital, Ibadan Nigeria. The case notes of all the HIV positive 
pregnant women and their comparison group who delivered in the year 2013(January 1st- December 31st) were retrieved. Data 
was summarized with frequency tables and mean (SD). Association between categorical variables was analyzed using chi-square 
test or Fisher test and association between continuous variables were analyzed using independent T-test. A probability value of 
<0.05 was considered statistically significant. Compared with the HIV negative women the HIV positive women had higher 
parity (p<0.001), lesser educational qualifications (p=0.004) and lower occupational positions (p<0.001). The differences for 
selected pregnancy and neonatal outcomes were not statistically significant; antenatal complications, blood loss at delivery, 
gestational age at delivery, birthweight of the babies, Apgar score, perinatal death and congenital anomalies. The socio-
demographic characteristics were different in both groups and highlight need for programs to address these factors. 
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INTRODUCTION 
 
Human Immunodeficiency Virus (HIV) infection remains a 
global burden and a major health challenge in sub-Saharan 
Africa including Nigeria (Onah et al., 2007). Reports have 
shown that Nigeria has the second highest number of people 
living with HIV after South Africa (World Fact Book, 2014). 
HIV prevalence rate among adults aged 15-49 years is 3.2%, 
which translates to about 3.4 million Nigerians (Awofala and 
Ogundele, 2016). Young adults especially women within the 
reproductive age group are mainly affected (Ezechi et al., 
2013). High incidence has also been reported within the 
paediatric age group due to vertical transmission of the disease 
(Onah et al., 2007). The use of Highly Active Antiretroviral 
Therapy (HAART) early in pregnancy based on World Health 
Organization (WHO) guidelines has helped in reduction of 
vertical transmission (Tyndall et al., 2011). Also, other 
measures such as elective cesarean section, the use of 
prophylactic antiretroviral by the exposed infant and exclusive 
breastfeeding within the first 6 months of life has also been 
incorporated to prevent mother-to-child transmission. With 
these measures, there has been a remarkable drop in the rate 
of vertical transmission of HIV (Haeri et al., 2009), but a 
significant number of cases still occur in resource limited 
countries like Nigeria (Tang et al., 2010).  
 Despite the obvious benefits of HAART in preventing 
mother-to-child transmission of HIV (PMTCT), the potential 
impact of these drugs in causing adverse obstetric and neonatal 
outcomes such as preterm delivery (PTB) and low birth weight 
(LBW) remain controversial (Ezechi et al., 2013; Townsend et 
al., 2007). While some studies have demonstrated little or no 
effects (Szyld et al., 2006), others have shown a wide range of 
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effects (Onah et al., 2007; Ezeaka et al., 2009; Ezechi et al., 
2013; St John et al., 2015). Thus, the main objective of this 
study was to compare the obstetrics and neonatal outcomes of 
HIV positive mothers with those of HIV negative mothers. 
 
MATERIALS AND METHODS 
 
Study design: This was a cross-sectional retrospective review 
study of records of HIV positive and HIV negative women.  
 
Study population: The study population included women 
who delivered in the labor ward of the University College 
Hospital, Ibadan between January 1st and December 31st 2013. 
 
Study area: It was carried out in the University College 
Hospital (UCH) Ibadan, Oyo State, Nigeria. UCH is located 
in the south-western geo-political zone of Nigeria. The 
hospital has 850 bed spaces and 163 examination couches. 
UCH offers prevention of mother-to-child transmission 
(PMTCT) services in the Anti-Retroviral Clinic supported by 
the AIDS Prevention Initiative in Nigeria (APIN) program. 
 
Sampling method: All HIV positive women who delivered in 
the labor ward of the University College Hospital, Ibadan 
between January 1st and December 31st 2013 were included. 
Also, the HIV negative women who delivered just before and 
just after the HIV positive women were included as the 
comparison group.  
 
Data collection: These patients were identified through the 
birth register and their case notes were thereafter retrieved.  
The data retrieved from the case notes included age, parity, 
last menstrual period and level of education. Others are 
antenatal complications, gestational age at delivery, mode of 
delivery, blood loss at delivery. Finally, information was also 
retrieved on the babies such as sex, birth weight, Apgar score, 
perinatal death and congenital anomalies. 




The data was entered and analyzed using IBM Statistical 
Package for Social Sciences Version 20, New York, US. Data 
was summarized with frequency tables and mean (SD). 
Association between categorical variables and HIV status of 
the women was analyzed using chi-square test or Fisher test 
where appropriate. Association between continuous variables 
were analyzed using independent T-test.  A probability value 
of <0.05 was considered statistically significant. However, 
only the data of the first twin in women who gave birth to 
twins were included in the analyses.  
 
Ethical Consideration: The confidentiality of these women 
was maintained as their names and personal data were not 
revealed. Codes were used instead of their names. Data 
obtained was anonymized. 
 Ethical approval was granted by the University of Ibadan 





Socio-demographics: During the study period, the records of 
320 women were retrospectively reviewed with 110 being 
HIV positive and 210 being HIV negative. Of these, 84 case 
records (76.3%) were retrieved for the HIV positive women 
and 133 (63.3%) were retrieved for the HIV negative women. 
The mean age of the women was 31.6 (4.4) years. Two 
hundred and fourteen (98.6%) of the women were married, 
majority (96.7%) had one form of formal education or the 
other and most (86.2%) were employed (see Table 1).  
 
Table 1.  
Sociodemographic characteristics of the women 




16-25 2(0.9%) 1(1.2%) 1(0.8%)  
 
0.43 
26-30 11(5.1%) 4(4.8%) 7(5.3%) 
31-35 51(23.5%) 14(16.7%) 37(17.1%) 
36-40 112(51.6%) 48(57.1%) 64(27.8%) 




0 63(29.0%) 17(20.2%) 46(34.6%)  
 
<0.001 
1 58(26.7%) 17(20.2%) 41(18.9%) 
2 73(33.6%) 35(41.7%) 38(30.8%) 
3 15(6.9%) 10(11.9%) 5(3.8%) 





Nil 8(3.7%) 7(8.3%) 1(0.8%)  
 
0.004 
Primary  8(3.7%) 7(8.3%) 1(0.8%) 
Secondary School 58(26.7%) 30(35.7%) 28(21.1%) 
Post-Secondary (not tertiary) 51(23.5%) 20(23.8%) 31(23.3%) 




Unemployed 30(13.8%) 9(10.7%) 21(15.8%)  
 
<0.001 
Self-Employed 111(51.2%) 57(67.9%) 54(40.6%) 
Civil Servant 41((18.9%)   11(13.1%) 30(22.6%) 
Professional 35(16.1%) 7(8.3%) 28(21.1%) 
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Table 2:  
Obstetric Characteristics 













Hypertension 17 (43.6%) 3 (3.6%) 14 (10.5%)  
PROM 6 (15.4%) 4 (4.8%) 2 (1.5%) 0.117 
APH 5 (12.8%) 1 (1.2%) 4 (3.0%)  
Others 7 (17.9%) 4 (4.8%) 3 (2.3%)  
Hypertension and 
Diabetes Mellitus 
2 (5.1%) 1 (1.2%) 1(0.8%)s  
Mode of delivery 
SVD 86 (39.6%) 27(32.1%) 59(44.4%)  
Assisted breech delivery 2 (0.9%) 1(1.2%) 1(0.8%) 0.315 
Emergency CS 75 (34.6%) 32 (38.1%) 43 (32.3%)  
Elective CS 53 (24.4%) 24(28.6%) 29 (21.9%)  
Vacuum 1 (0.5%) 0(0) 1 (0.8%)  
 
Table 3  
Neonatal Outcomes 
Variable All Women (217) HIV +ve(84) HIV –ve(133) p – Value 
 
Perinatal death 
    
Yes 11(5.1%) 5(5.95%) 6(4.5%)  
No 206(94.9%) 79(94.0%) 127(95.4%) 0.753 
Congenital Anomaly     
Yes 3(1.4%) 1(1.2%) 2(1.5%) 1.000 
No 214(98.6%) 83(98.8%) 131(98.5%)  
Apgar Score     
Normal  193(95.1%) 76(90.5%) 117(88.0%)  
Mild Asphyxia 5(2.5%) 3(3.57%) 2(1.5%) 0.269 
Moderate Asphyxia 4(2.0%) 0 4(3.0%)  
Severe Asphyxia 1(0.5%) 0 1(0.8%)  
 
 
Pregnancy, birth and neonatal outcomes: Only 39 (18.3%) 
had antenatal complications with the most common being 
hypertension (17.8%). Eighty-six (39.6%) of the women 
delivered via spontaneous vaginal delivery, 75 (34.6%) by 
emergency caesarean section and 53 (24.4%) by elective 
caesarean section. There was only one case of vacuum 
delivery.  
The mean birth weight was 3.06kg (±0.56) and the mean 
gestational age at delivery was 38.6weeks (2.31). Eleven 
(5.1%) cases of perinatal deaths and 3 (1.4%) of congenital 
anomalies were recorded.  
 
Association between HIV status and demographics: The 
sociodemographic characteristics of the HIV positive women 
and their controls were compared. The HIV positive women 
were noted to have a higher parity (p < 0.001) and lesser 
educational qualifications (p < 0.004). The HIV negative 
women had higher proportion of professionals (21.1% vs 
8.3%) and government workers (22.6% vs 13.1%) when 
compared to the HIV positive who had higher proportion of 
self-employment (67.9% vs 40.6%) (p < 0.001) (Table 1). 
 
Association between HIV status and pregnancy, birth and 
neonatal outcomes: Thirty-nine of the women had one or 
more antenatal complication with two reported as having both 
hypertension and diabetes.   
 The HIV positive women had fewer cases of hypertensive 
disorders (3.6% vs 10.5%), had more deliveries by caesarean 
section (66.7% vs 54.2%), higher blood loss at delivery 
(376.8ml vs 353.3ml). However, these differences were not 
statistically significant. A review of the neonatal outcomes 
showed that the HIV positive parturient had babies with lower 
mean birth weight [2.98kg (0.5) vs 3.07kg ( 0.6) p=0.168] but 
the gestational age at delivery was similar for both HIV 
positive and negative groups [(38.5weeks (2.2) vs 38.7 weeks 
(2.4) p=0.975]. Finally, fewer babies with moderate or severe 






The mean age of the mothers was 31.6years (4.4) which is 
similar to the mean age reported by Adesina et al., (2015a) in 
Ibadan and Van der Merwe et al., (2011) in South Africa. This 
study reported higher parity, lesser educational qualifications 
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and lower occupational positions/unemployment amongst 
HIV positive mothers in comparison to HIV negative women 
which is similar to the findings of Figueroa-Cosme et al., 
(2010) in Puerto – Rico and Adejuyigbe et al., (2004) in Ile-
Ife. Different variables including occupation, type of housing 
and years of education have been used by different authors as 
proxy socioeconomic variables (Frank et al., 2004; Gluckman 
et al., 2008; Ahmadu et al., 2013).  When level of education is 
used as proxy for socio-economic class (SEC), fewer years of 
education are associated with lower classes of SEC. Poor 
socioeconomic background of women has been described as 
important predictors of adverse pregnancy outcomes such as 
spontaneous preterm delivery (Tucker and McGuire, 2004) 
and low birth weight (Kogan, 1995; Torres-Arreola et al., 
2005). It has been suggested that the effect of low SEC factors 
start at the time of conception through low physiologic 
reserves, inadequate medical care and high risk of infectious 
disease (Gluckman et al., 2008). In addition, women with 
more years of education could be exposed to information on 
the importance of prenatal health care which could encourage 
healthy practices (Kogan, 1995; Torres-Arreola LP et al., 
2005). 
 Low birth weight has been a recurring outcome in past 
researches carried out on the obstetrics, birth and neonatal 
outcomes of HIV positive women (Haeri et al., 2009; Ezechi 
et al 2013; Peng- Lei Xiao et al., 2015). However, this study 
found no statistically significant difference between HIV 
positive and HIV negative babies even though the mean birth 
weight of babies born to HIV positive mothers was lower. This 
is consistent with the findings of Habib et al., (2008), Onah et 
al., (2007), Vincent-Tyndall et al., (2011) and Adesina et al., 
(2015a). 
 Also, this study found no significant statistical association 
between preterm delivery and HIV status of the mother as 
reported by Onah et al., (2007) which is in contrast to the 
findings of Figueroa-Cosme et al (2010), Brocklehurst and 
French. (1998), Aebi – Popp et al (2010). The effect of 
antiretroviral therapy on prevalence of PTB among HIV +ve 
women remains unclear. While some authors demonstrated 
increased risk of PTB with antiretrovirals (Townsend et al., 
2007; ECS. 2000; Van der Merwe et al., 2011, Ezechi et al., 
2012), others demonstrated no such increase (Szyld et al., 
2006; Yu L et al., 2012). A possible reason proffered for the 
association of PTB with HIV and ARV is the Th2 to Th1 
cytokine shift associated with HAART administration (Fiore 
et al., 2006). This is in contrast to the Th1 to Th2 shift 
observed in successful pregnancies (Fiore et al., 2006, 
Adesina et al.,2015a).    
 Furthermore, no statistically significant association was 
found between HIV status and other obsterics, birth and 
neonatal outcomes which includes the mode of delivery, 
antenatal complications, Apgar score, perinatal death, 
congenital anomaly and mean blood loss. Similar findings 
have been reported by Tyndall et al., (2011) and Haeri et al., 
(2009). The use of elective CS prior to the onset of labor can 
reduce the rate of MTCT by about 50% (Kuhn et al., 2008). 
Despite this benefit, there is an aversion towards CS among 
Nigerian women (Ezechi et al., 2004). However, an aggressive 
reduction in viral load during the antenatal period may allow 
the more culturally acceptable option of vaginal delivery to be 
practiced (Mofenson, 2002; Shapiro et al., 2010), while 
ensuring a sustained reduction in vertical transmission of HIV. 
Indeed, Adesina et al., (2015b) reported an increase from 
64.8% to 73.5% of vaginal delivery with introduction of 
universal HAART for all HIV positive pregnant women at the 
UCH and implementation of the WHO rapid advice (Use of 
Antiretroviral Drugs for Treating Pregnant Women and 
Preventing HIV Infection in Infants). A possible explanation 
for this lack of association between HIV status and other 
outcomes of interest is the improved use of Highly Active 
Antiretroviral therapy (HAART) during pregnancy by the 
HIV positive women as most of the women were on HAART. 
However, an important limitation of this study is the small 
sample size of the HIV positive women and their controls. 
 In conclusion, very few differences in obstetric and 
neonatal outcomes were noted when HIV positive and HIV 
negative women were compared. This is reassuring given the 
benefits of HAART in preventing mother-to-child 
transmission of HIV. Nonetheless, health care providers must 
continue to carefully evaluate for any adverse effects. 
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